Cart
sales@molnova.com
FIIN-4
CAS No. 2093088-81-2
FIIN-4( —— )
Catalog No. M34253 CAS No. 2093088-81-2
FIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 455 | In Stock |
|
| 10MG | 620 | In Stock |
|
| 25MG | 941 | In Stock |
|
| 50MG | 1237 | In Stock |
|
| 100MG | 1628 | In Stock |
|
| 200MG | 2204 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFIIN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionFIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.
-
DescriptionFIIN-4 is a small molecule cysteine-targeting covalent kinase inhibitor (CKI).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2093088-81-2
-
Formula Weight634.73
-
Molecular FormulaC35H38N8O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N1C=2C(CN(C1=O)C3=CC(OC)=CC(OC)=C3)=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N2)C6=CC(NC(C=C)=O)=CC=C6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Alofanib
Alofanib is a selective allosteric inhibitor of FGFR2 and has a dramatic inhibitory effect on FGF2-induced phosphorylation of FRS2a in KATO III cells (IC50 <10 nM).
-
Infigratinib
Infigratinib (NVP-BGJ398, BGJ398) is a potent, selective pan-FGFR inhibitor.
-
Palifosfamide
Palifosfamide lysine (ZIO-201) is a stable form of palifosfamide. Palifosfamide lysine has broad activity in sarcoma lines in vitro.
